Paper41572017
Prevalence of diplopia among giant cell arteritis patients: a systematic review and meta-analysis.
Dhivagaran T and 8 others. Eye (Lond), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Prevalence of diplopia among giant cell arteritis patients: a systematic review and meta-analysis. Papers, record 41572017. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41572017
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prevalence of diplopia among giant cell arteritis patients: a systematic review and meta-analysis.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diplopia | Major topic |
| Giant Cell Arteritis | Major topic |
| Humans | |
| Prevalence |
Source PubMed
References22
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25817017 | A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility. | Am J Hum Genet | 2015 | https://conductscience.org/library/papers/25817017 | PubMed |
| 2 | 19196636 | Giant cell arteritis and mortality. | J Gerontol A Biol Sci Med Sci | 2009 | https://conductscience.org/library/papers/19196636 | PubMed |
| 3 | 33463564 | Giant cell arteritis: Its ophthalmic manifestations. | Indian J Ophthalmol | 2021 | https://conductscience.org/library/papers/33463564 | PubMed |
| 4 | 29697441 | Retrospective, Multicenter Comparison of the Clinical Presentation of Patients Presenting With Diplopia From Giant Cell Arteritis vs Other Causes. | J Neuroophthalmol | 2019 | https://conductscience.org/library/papers/29697441 | PubMed |
| 5 | 8024610 | Giant cell arteritis in Iceland. An epidemiologic and histopathologic analysis. | Arthritis Rheum | 1994 | https://conductscience.org/library/papers/8024610 | PubMed |
| 6 | 4202423 | Giant cell arteritis--the need for prolonged treatment. | J Chronic Dis | 1973 | https://conductscience.org/library/papers/4202423 | PubMed |
| 7 | 7259802 | The epidemiology of giant cell arteritis including temporal arteritis and polymyalgia rheumatica. Incidences of different clinical presentations and eye complications. | Arthritis Rheum | 1981 | https://conductscience.org/library/papers/7259802 | PubMed |
| 8 | 23663687 | Ocular involvement in giant cell arteritis. | Clin Exp Rheumatol | 2013 | https://conductscience.org/library/papers/23663687 | PubMed |
| 9 | 9457462 | Neuro-ophthalmic complications of biopsy-proven giant cell arteritis. | Eur J Ophthalmol | 1997 | https://conductscience.org/library/papers/9457462 | PubMed |
| 10 | 9704651 | Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. | Arthritis Rheum | 1998 | https://conductscience.org/library/papers/9704651 | PubMed |
| 11 | 24986968 | Incidence and prognostic implications of diplopia in patients with giant cell arteritis. | J Rheumatol | 2014 | https://conductscience.org/library/papers/24986968 | PubMed |
| 12 | 9559737 | Ocular manifestations of giant cell arteritis. | Am J Ophthalmol | 1998 | https://conductscience.org/library/papers/9559737 | PubMed |
| 13 | 493941 | Temporal arteritis. A 14-year epidemiological, clinical and prognostic study. | Scott Med J | 1979 | https://conductscience.org/library/papers/493941 | PubMed |
| 14 | 7800356 | Visual morbidity in giant cell arteritis. Clinical characteristics and prognosis for vision. | Ophthalmology | 1994 | https://conductscience.org/library/papers/7800356 | PubMed |
| 15 | 19593227 | Takayasu arteritis and giant cell arteritis: a spectrum within the same disease? | Medicine (Baltimore) | 2009 | https://conductscience.org/library/papers/19593227 | PubMed |
| 16 | 19179409 | Do temporal artery duplex ultrasound findings correlate with ophthalmic complications in giant cell arteritis? | Rheumatology (Oxford) | 2009 | https://conductscience.org/library/papers/19179409 | PubMed |
| 17 | 35878473 | A nationwide study of ocular manifestations leading to hospital contacts among patients with giant cell arteritis. | Semin Arthritis Rheum | 2022 | https://conductscience.org/library/papers/35878473 | PubMed |
| 18 | 33407817 | Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations. | Arthritis Res Ther | 2021 | https://conductscience.org/library/papers/33407817 | PubMed |
| 19 | 14189726 | TEMPORAL ARTERITIS. | Br J Ophthalmol | 1963 | https://conductscience.org/library/papers/14189726 | PubMed |
| 20 | 28539785 | Giant cell arteritis: a review. | Eye Brain | 2013 | https://conductscience.org/library/papers/28539785 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41572017
GET https://conductscience.org/api/papers/v1/41572017/references?page=2